Reed's (REED) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
12 Nov, 2026Executive summary
Q3 gross profit and margin improved, operating expenses and net loss declined, while net sales remained lower YoY.
Nine-month sales declined 20% to $21,143 thousand and net loss widened to $13,907 thousand; operating cash use was $8,329 thousand.
A post-quarter $10 million related-party equity placement supported liquidity, but the filing identified substantial doubt about ability to continue as a going concern.
Financial highlights
Q3 net sales fell 7% YoY to $6,513 thousand; gross profit rose 34% to $1,635 thousand from $1,224 thousand.
Q3 operating loss narrowed to $2,956 thousand from $4,103 thousand; net loss narrowed to $3,170 thousand from $3,982 thousand.
Q3 SG&A declined 15% to $3.6M from $4.2M; 9M operating expenses were $17.4M versus $17.1M.
Q3 EBITDA loss was $2,875 thousand versus $3,607 thousand; 9M EBITDA loss was $13,015 thousand versus $10,956 thousand.
Nine-month gross profit was $4,121 thousand versus $5,433 thousand; net loss was $13,907 thousand versus $12,061 thousand.
Outlook and guidance
Management expects sequential operating improvement, with Q4 sales and gross margin expected to improve from Q3 and exceed the prior-year period.
Gross-margin focus is on modest Q4 improvement and reaching the mid-30% range around Q2 2027.
Priorities include profitable sales growth, disciplined commercial execution, targeted marketing, product innovation, freight-cost reduction, portfolio optimization and supply-chain improvements.
More than 3,000 retail doors were added YoY; placements are expected to contribute more in Q4 and 2027, with account returns mainly in Q1–Q2 2027.
A new product is targeted for early 2027, initially through a controlled test with selected local customers and retail partners.
Latest events from Reed's
- Gross margin rose to 24% in Q2 2026, but liquidity and NYSE compliance risks remain.REED
Q2 2026 - All proposals, including director elections and equity plan, were approved without shareholder questions.REED
AGM 2026 - Net sales fell 29% to $7.1M, gross margin dropped to 10%, and corrective actions are underway.REED
Q1 2026 - Annual meeting to vote on directors, auditor, equity plan, and executive pay, with board support.REED
Proxy filing - Annual meeting to vote on directors, auditor, equity plan, and executive pay, June 10, 2026.REED
Proxy filing - Sequential improvements and new growth initiatives set the stage for margin expansion in 2026.REED
Q4 2025 - Net sales and margins dropped, but new funding and restructuring target 2025 recovery.REED
Q3 2024 - Q2 2024 saw double-digit sales growth, margin gains, and improved but still risky profitability.REED
Q2 2024 - Gross margin surged to 30% as debt fell and new products set the stage for 2025 growth.REED
Q4 2024